Agilon Health

Agilon Health, Inc. is a healthcare company, enables primary care physicians (PCPs) to be agents in the communities they serve. It provides healthcare for seniors across communities throughout the United States and has created an agilon Platform, which is a Total Care Model for community-based physicians. The firm serves a Total Care Model which focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with the Centers for Medicare and Medicaid services. The company was founded in 2016 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Agilon Health reports strong 2022 performance and optimistic growth outlook

Agilon Health had a successful 2022, with strong financial performance and a focus on transforming healthcare through empowering primary care doctors. The company is optimistic about future growth, managing challenges in margins and financial management while leveraging opportunities in partnerships and operational efficiency.

Agilon Health triples Q1 earnings, eyes growth through partnerships

Agilon Health (AGL) delivered robust Q1 2023 results, maintaining outlook and confidence in clinical programs for high-cost patients and new partnerships.
Effective management of costs and revenues, alongside strategic acquisitions and partnerships, underpin the company's growth trajectory.
Challenges include margin impacts from external factors and managing costs associated with market expansion, balanced by opportunities in network growth and market transition.
The company's performance, strengths, challenges, and opportunities collectively shape its strategic direction towards sustained growth and operational excellence.

Agilon Health excels in Q2 2023, eyes growth opportunities

Agilon Health's strong financial performance in Q2 2023 underscores its operational excellence and growth potential. While challenges like revenue projections and medical margin variations exist, the company's strategic focus on risk adjustment and payer partnerships presents significant opportunities for future success.

Agilon Health reports strong Q3 performance, eyes growth opportunities

Agilon Health's Q3 2023 performance reflects robust growth in partner markets and revenue, supported by a unique model driving clinical and financial success.
While facing challenges in cash flow and benefit pullbacks, the company is well-positioned to leverage opportunities for growth and operational enhancement in '24.
Strategic decisions like selling the Hawaii business and focusing on core markets demonstrate a commitment to sustainable growth and operational efficiency.

Agilon Health addresses challenges, focuses on growth opportunities in 2024

Agilon Health faces challenges with medical margins but is making progress on their 2024 performance action plan to drive improvement.
The company is focusing on data visibility, quality partnerships, and efficiency gains to navigate the dynamic utilization environment and achieve growth.
Despite higher cash burn in 2024, Agilon anticipates positive cash flow from 2025 onwards if they meet their guidance and address payer negotiations.
Opportunities lie in a measured growth approach, cohort progression, and tuning payer arrangements to reflect the value provided by Agilon's services.

Agilon Health reports strong Q1 growth, navigates healthcare challenges

Agilon Health's Q1 '24 performance showcased growth in membership, revenue, medical margin, and adjusted EBITDA, despite challenges in cost trends and utilization.
The company's strategic focus on value-based care partnerships, data analytics, and operational efficiency positions them well for future growth and profitability.
While facing challenges in cost management and contract negotiations, Agilon Health is actively pursuing opportunities in sustainable payer contracts, technology enhancements, and benefit expansions.

Agilon Health reports strong Q2 performance and strategic growth outlook

Agilon Health's Q2 2024 earnings call reflects robust performance, operational strengths, strategic challenges, and growth opportunities in the evolving healthcare landscape.
The company's focus on refining payer relationships, enhancing data visibility, and driving operational efficiency positions it well for sustained success and market expansion.
Despite facing financial challenges and navigating payer dynamics, Agilon Health's proactive approach to innovation and leadership changes signals a commitment to long-term growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your agilon investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws,.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of agilon health, inc. (AGL) on Behalf of Investors

NEW YORK , March 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL).

agilon health, inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AGL

LOS ANGELES, CA / ACCESSWIRE / March 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against agilon health, inc. and Encourages Investors with Losses to Contact the Firm

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) investors concerning the Company's possible violations of federal securities laws. On November 2, 2023, agilon released its third quarter 2023 financial results, reporting lower-than-expected numbers due to increased utilization and medical costs. Additionally, the Company lowered its full-year guidance, stating that it had increased.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of agilon health, inc.

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against agilon health, inc. (NYSE: AGL) (“agilon” or the “Company”) on behalf of investors who purchased or acquired agilon common stock between November 4, 2022, and January 4, 2024, inclusive (the “Class Period”). This action, captioned Hope v. agilon health, inc., et al., Case No. 1:24-cv-00305, is filed in the United Sta.

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of agilon health, inc. (NYSE: AGL): (i) pursuant and/or traceable to the offering documents issued in connection with the Company's May 2023 secondary public offering (the “SPO” or “Offering”); and/or (ii) between January 9, 2023 and January 4, 2024, both dates inclusive (the “Class Period”). If you wish to serve as lead plaint.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AGL

NEW YORK, NY / ACCESSWIRE / March 25, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=72574&wire=1 or contact Joseph E.

Investors who Lost Money on Agilon Health, inc.(AGL) Should Contact Levi & Korsinsky About Pending Class Action - AGL

LOS ANGELES, CA / ACCESSWIRE / March 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against agilon health, inc. and Encourages Investors with Losses to Contact the Firm

Alto Ingredients

AT&T

T, AGL and ALTO have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2023.

New Strong Sell Stocks for March 25th

NEW ORLEANS , March 22, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL), if they i) purchased or otherwise acquired the Company's shares between January 9, 2023 and January 4, 2024, inclusive (the "Class Period"), and/or ii) purchased or otherwise acquired the Company's shares pursuant or traceable to the Company's May 2023 secondary public offering ("SPO").

AGILON HEALTH SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against agilon health, inc. - AGL

SAN DIEGO--(BUSINESS WIRE)---- $AGL #SPO--Robbins LLP is Investigating the Allegations that agilon health, inc. (AGL) Misled Investors Regarding Medical Costs.

agilon health, inc. (AGL) Stockholder Alert: Robbins LLP Reminds Investors of AGL Class Action

SAN DIEGO , March 22, 2024 /PRNewswire/ -- DiCello Levitt LLP announces that purchasers or acquirers of Agilon Health, Inc. ("Agilon" or the "Company") (NYSE: AGL) common stock between January 9, 2023 and January 4, 2024, inclusive (the "Class Period"), have until May 20, 2024 to seek appointment as lead plaintiff of the Agilon class action lawsuit. The Agilon lawsuit charges the Company, certain senior executive officers, and the Company's underwriters with violations of the federal securities laws.

Investor Alert: Investor Class Action Lawsuit Filed Against Agilon Health, Inc. (NYSE: AGL)

LOS ANGELES, CA / ACCESSWIRE / March 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against agilon health, inc. and Encourages Investors with Losses to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 21, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=72181&wire=1 or contact Joseph E.

Shareholders That Lost Money on agilon health, inc. (AGL) Should Contact Levi & Korsinsky About Pending Class Action - AGL

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL), if they i) purchased or otherwise acquired the Company's shares between January 9, 2023 and January 4, 2024, inclusive (the “Class Period”), and/or ii) purchased or.

AGILON HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against agilon health, inc. - AGL

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On November 2, 2023, agilon released its third quarter 2023 financial results, reporting lower-than-expected numbers due to increased utilization and medical costs. Additionally.

The Law Offices of Frank R. Cruz Announces Investigation of agilon health, inc.

NEW YORK, NY / ACCESSWIRE / March 21, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=72160&wire=1 or contact Joseph E.

Levi & Korsinsky Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 – AGL

LOS ANGELES, CA / ACCESSWIRE / March 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against agilon health, inc. and Encourages Investors with Losses to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 20, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=71983&wire=1 or contact Joseph E.

agilon health, inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights – AGL

NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) announces that, on March 19, 2024, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client the New England Teamsters Pension Fund (“New England Teamsters”) against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and related parties (collectively, “Defendants”). The action, which is captioned New England Teamsters Pension Fund v. agilon health, inc., No. 24-cv-00297 (W.D. Tex.), asserts cl.

Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against agilon health, inc. and Related Parties

BankFinancial

Sleep Number

AGL, BFIN and SNBR have been added to the Zacks Rank #5 (Strong Sell) List on March 15, 2024.

New Strong Sell Stocks for March 15th

Bel Fuse

Driven Brands Holdings

AGL, BELFB and DRVN have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2023.

New Strong Sell Stocks for February 28th

agilon health, Inc. (AGL) Q4 2023 Earnings Call Transcript

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say

Agilon Health (AGL) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.14 per share a year ago.

News for Agilon Health Stock (AGL)